News
-
Opioid access summit
Tuesday | May 8 2018HARM Reduction Australia and ScriptWise are joining forces to host a national summit in Canberra on 23 May to "re-think outdated policies and increase access to opioid treatment".
-
ASMI slams Hawaii sunscreen move
Tuesday | May 8 2018THE Australian Self Medication Industry (ASMI) regulatory and legal director Steve Scarff has expressed concern about reports the Hawaiian Government may ban the sale of sunscreen products containing oxybenzone and octinoxate without a prescription.
-
Spinraza PBS funded
Tuesday | May 8 2018EFFECTIVE 01 Jun, spinal muscular atrophy (SMA) life-changing lumbar-puncture administered medication Spinraza (nusinersen from Biogen) is to be funded on the PBS, according to an announcement by Federal Treasurer Scott Morrison on the weekend - info at biogen.com.au.
-
Droperidol use in Oz
Tuesday | May 8 2018PARAMEDICS in Australia have become the first to use new antidopaminergic drug droperidol to quickly and safely calm patients who have become violent under the influence of alcohol and drugs.
-
NICE cancer support
Tuesday | May 8 2018THE UK National Institute for Health and Care Excellence (NICE) has recommended that cancer patients in the UK have access to three blood cancer drugs, brentuximab vedotin, midostaurin and arsenic trioxide via the NHS.
-
Irish pharmacy crisis
Tuesday | May 8 2018SOME pharmacies in Northern Ireland may end up closing their doors for good, with representative group Community Pharmacy Northern Ireland highlighting a 20 million funding gap.
-
ACMS deferral
Tuesday | May 8 2018BENZYL salicylate, anise alcohol and cinnamaldehyde have been removed from the proposal to amend the Poisons Standard referred to the Jun 2018 meeting of the Joint Advisory Committees on Medicines and Chemicals Scheduling.
-
Coughing attack
Tuesday | May 8 2018THE Federal Government will up its attack on the whooping cough bacterium by offering free vaccination to all pregnant women, with details to come in the budget.
-
Biosimilars push
Tuesday | May 8 2018HUMIRA (adalimumab) biosimilars will have significant uptake in the EU with pricing at 10-20% lower than the originator brand across the EU, according to a report from analytics company GlobalData.
-
Dispensary Corner
Tuesday | May 8 2018
08 May 18ANYONE who says you should keep an ear out for signs of a bug infestation should think about revising their advice, after a 29-year-old woman from Florida had a cockroach take up residence in her aural canal.
